R. Frénais

589 total citations
15 papers, 421 citations indexed

About

R. Frénais is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Infectious Diseases. According to data from OpenAlex, R. Frénais has authored 15 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Surgery and 4 papers in Infectious Diseases. Recurrent topics in R. Frénais's work include Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Lipoproteins and Cardiovascular Health (5 papers) and Dermatological diseases and infestations (4 papers). R. Frénais is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers), Lipoproteins and Cardiovascular Health (5 papers) and Dermatological diseases and infestations (4 papers). R. Frénais collaborates with scholars based in France, South Africa and United States. R. Frénais's co-authors include Michel Krempf, Khadija Ouguerram, Janina Taenzler, Anja R. Heckeroth, Cyrille Maugeais, T. Magot, Julian Liebenberg, Rainer K. A. Roepke, Jean‐Marie Bard and Ivan G. Horak and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Nutrition and Journal of Lipid Research.

In The Last Decade

R. Frénais

15 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Frénais France	13	188	148	117	75	73	15	421
Jiawen Dong China	12	73 0.4×	41 0.3×	108 0.9×	156 2.1×	15 0.2×	35	420
Hugo Carrasco Venezuela	15	101 0.5×	64 0.4×	20 0.2×	639 8.5×	18 0.2×	36	903
Patricia Ferrer Argentina	10	72 0.4×	70 0.5×	21 0.2×	74 1.0×	5 0.1×	23	480
Leïla Houti Algeria	7	51 0.3×	26 0.2×	24 0.2×	61 0.8×	9 0.1×	19	262
Ray Danner United States	6	117 0.6×	92 0.6×	31 0.3×	41 0.5×	32 0.4×	7	384
Jing Ding China	13	25 0.1×	30 0.2×	162 1.4×	44 0.6×	60 0.8×	44	499
Nicola Schaltenberg Germany	9	31 0.2×	61 0.4×	51 0.4×	137 1.8×	24 0.3×	10	567
B. P. Niranjan Reddy India	11	30 0.2×	13 0.1×	39 0.3×	49 0.7×	8 0.1×	18	452
Amanda E. Crunk United States	9	38 0.2×	59 0.4×	26 0.2×	93 1.2×	38 0.5×	11	541
Mohammed Abdalla United Kingdom	12	122 0.6×	46 0.3×	6 0.1×	54 0.7×	26 0.4×	40	606

Countries citing papers authored by R. Frénais

Since Specialization

Citations

This map shows the geographic impact of R. Frénais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Frénais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Frénais more than expected).

Fields of papers citing papers by R. Frénais

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Frénais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Frénais. The network helps show where R. Frénais may publish in the future.

Co-authorship network of co-authors of R. Frénais

This figure shows the co-authorship network connecting the top 25 collaborators of R. Frénais. A scholar is included among the top collaborators of R. Frénais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Frénais. R. Frénais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Frénais, R., et al.. (2018). Laboratory assessment of the anti-feeding effect for up to 12 months of a slow release deltamethrin collar (Scalibor®) against the sand fly Phlebotomus perniciosus in dogs. Parasites & Vectors. 11(1). 529–529. 13 indexed citations

Taenzler, Janina, et al.. (2017). Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats. Parasites & Vectors. 10(1). 30–30. 37 indexed citations

Taenzler, Janina, Julian Liebenberg, Rainer K. A. Roepke, R. Frénais, & Anja R. Heckeroth. (2016). Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs. Parasites & Vectors. 9(1). 392–392. 37 indexed citations

Fourie, Josephus, Julian Liebenberg, Ivan G. Horak, et al.. (2015). Efficacy of orally administered fluralaner (BravectoTM) or topically applied imidacloprid/moxidectin (Advocate®) against generalized demodicosis in dogs. Parasites & Vectors. 8(1). 187–187. 67 indexed citations

Frénais, R., et al.. (2014). Anti-feeding efficacy of Activyl® Tick Plus topical treatment of dogs against Phlebotomus perniciosus. Parasites & Vectors. 7(1). 217–217. 4 indexed citations

Frénais, R., et al.. (2009). Clinical efficacy and safety of a once‐daily formulation of carbimazole in cats with hyperthyroidism. Journal of Small Animal Practice. 50(10). 510–515. 12 indexed citations

Frénais, R., et al.. (2008). Pharmacokinetics of controlled‐release carbimazole tablets support once daily dosing in cats. Journal of Veterinary Pharmacology and Therapeutics. 31(3). 213–219. 13 indexed citations

Pouteau, Etienne, R. Frénais, H. Dumon, et al.. (2005). Colonic Fermentation of Inulin Increases Whole-Body Acetate Turnover in Dogs. Journal of Nutrition. 135(12). 2845–2851. 8 indexed citations

Bach‐Ngohou, Kalyane, Khadija Ouguerram, R. Frénais, et al.. (2005). Influence of Atorvastatin on Apolipoprotein E and AI Kinetics in Patients with Type 2 Diabetes. Journal of Pharmacology and Experimental Therapeutics. 315(1). 363–369. 27 indexed citations

10.

Bach‐Ngohou, Kalyane, Khadija Ouguerram, Hassan Nazih, et al.. (2002). Apolipoprotein E kinetics: influence of insulin resistance and type 2 diabetes. International Journal of Obesity. 26(11). 1451–1458. 18 indexed citations

11.

Frénais, R., Hassan Nazih, Khadija Ouguerram, et al.. (2001). In VivoEvidence for the Role of Lipoprotein Lipase Activity in the Regulation of Apolipoprotein AI Metabolism: A Kinetic Study in Control Subjects and Patients with Type II Diabetes Mellitus¹. The Journal of Clinical Endocrinology & Metabolism. 86(5). 1962–1967. 37 indexed citations

12.

Frénais, R.. (2001). Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitus. Atherosclerosis. 157(1). 131–135. 20 indexed citations

13.

Maugeais, Cyrille, Khadija Ouguerram, R. Frénais, et al.. (2001). Effect of Low-Density Lipoprotein Apheresis on Kinetics of Apolipoprotein B in Heterozygous Familial Hypercholesterolemia1. The Journal of Clinical Endocrinology & Metabolism. 86(4). 1679–1686. 13 indexed citations

14.

Frénais, R., Khadija Ouguerram, Cyrille Maugeais, et al.. (1999). Apolipoprotein A-I kinetics in heterozygous familial hypercholesterolemia: a stable isotope study. Journal of Lipid Research. 40(8). 1506–1511. 47 indexed citations

15.

Frénais, R., et al.. (1997). High density lipoprotein apolipoprotein AI kinetics in NIDDM: a stable isotope study. Diabetologia. 40(5). 578–583. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact